These substances are evaluated based on safety and available evidence, with certain peptides categorized as ineligible for compounding due to potential risk (FDA, 2025)
A serum B12 level test and, ideally, a methylmalonic acid (MMA) test should precede any B12 injection recommendation
These quality specifications ensure the reconstitution solvent does not introduce endotoxin, microbial, particulate, or chemical contamination into reconstituted research compound solutions
Published online 2013
19 Stem cell therapies, utilizing mesenchymal stem cells (MSCs), bone marrow-derived stem cells (BMSCs), and tissue-derived mesenchymal stem cells (TDMSCs), take advantage of the intrinsic ability of these cells to differentiate into various cell types and modulate their microenvironment through paracrine signaling